Literature DB >> 27083461

Continuous subcutaneous insulin infusion therapy for Type 1 diabetes mellitus in children.

M Mavinkurve1, A Quinn2, C S O'Gorman3,4.   

Abstract

PURPOSE: Continuous subcutaneous insulin pump therapy (CSII or pump therapy) is a well-recognised treatment option for Type 1 diabetes mellitus (T1DM) in paediatrics. It is especially suited to children because it optimises control by improving flexibility across age-specific lifestyles. The NICE guidelines (2008) recognise that pump therapy is advantageous and that it should be utilised to deliver best practice. In Ireland, the National Clinical Program for Diabetes will increase the availability and uptake of CSII in children and thus more clinicians are likely to encounter children using CSII therapy.
METHODS: This is a narrative review which discusses the basic principles of pump therapy and focuses on aspects of practical management.
RESULTS: Insulin pump management involves some basic yet important principles which optimise the care of diabetes in children.
CONCLUSIONS: This review addresses the principles of insulin pump management in children which all health care professionals involved in caring for the child with diabetes, shoud be familiar with.

Entities:  

Keywords:  Continuous subcutaneous insulin infusion; Insulin Pump Therapy; Paediatrics; Type 1 diabetes mellitus

Mesh:

Substances:

Year:  2016        PMID: 27083461     DOI: 10.1007/s11845-016-1441-7

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  20 in total

1.  Neonatal diabetes and insulin pump therapy.

Authors:  Kathryn Beardsall; Claire L Pesterfield; Carlo L Acerini
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2010-11-29       Impact factor: 5.747

2.  Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life.

Authors:  S K McMahon; F L Airey; D A Marangou; K J McElwee; C L Carne; A J Clarey; E A Davis; T W Jones
Journal:  Diabet Med       Date:  2005-01       Impact factor: 4.359

3.  Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.

Authors:  Y Levy-Shraga; L Lerner-Geva; D Modan-Moses; C Graph-Barel; K Mazor-Aronovitch; V Boyko; O Pinhas-Hamiel
Journal:  Exp Clin Endocrinol Diabetes       Date:  2013-01-17       Impact factor: 2.949

Review 4.  Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials.

Authors:  Ewa Pańkowska; Marlena Błazik; Piotr Dziechciarz; Agnieszka Szypowska; Hania Szajewska
Journal:  Pediatr Diabetes       Date:  2008-08-27       Impact factor: 4.866

5.  Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study.

Authors:  Stephanie R Johnson; Matthew N Cooper; Timothy W Jones; Elizabeth A Davis
Journal:  Diabetologia       Date:  2013-08-21       Impact factor: 10.122

6.  Services for children with diabetes.

Authors:  T Savage; A Clarke; C Costigan; B G Loftus; D Cody
Journal:  Ir Med J       Date:  2008-01

7.  Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy.

Authors:  Scott M Blackman; Dan Raghinaru; Saleh Adi; Jill H Simmons; Laurie Ebner-Lyon; H Peter Chase; William V Tamborlane; Desmond A Schatz; Jennifer M Block; Jean C Litton; Vandana Raman; Nicole C Foster; Craig R Kollman; Stephanie N DuBose; Kellee M Miller; Roy W Beck; Linda A DiMeglio
Journal:  Pediatr Diabetes       Date:  2014-02-04       Impact factor: 4.866

Review 8.  Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.

Authors:  J C Pickup; A J Sutton
Journal:  Diabet Med       Date:  2008-07       Impact factor: 4.359

9.  Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes.

Authors:  Stuart A Weinzimer; Jennifer L Sherr; Eda Cengiz; Grace Kim; Jessica L Ruiz; Lori Carria; Gayane Voskanyan; Anirban Roy; William V Tamborlane
Journal:  Diabetes Care       Date:  2012-07-18       Impact factor: 19.112

Review 10.  Closed-loop insulin delivery for treatment of type 1 diabetes.

Authors:  Daniela Elleri; David B Dunger; Roman Hovorka
Journal:  BMC Med       Date:  2011-11-09       Impact factor: 8.775

View more
  1 in total

1.  Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review.

Authors:  Carolina Spinelli Alvarenga; Rebecca Ortiz La Banca; Rhyquelle Rhibna Neris; Valéria de Cássia Sparapani; Miguel Fuentealba-Torres; Denisse Cartagena-Ramos; Camila Lima Leal; Marcos Venicio Esper; Lucila Castanheira Nascimento
Journal:  BMC Endocr Disord       Date:  2022-02-19       Impact factor: 2.763

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.